Science
SARS-CoV-2 triggers antibodies from previous coronavirus infections – Drug Target Review
A new study has shown that previous coronavirus infection may contribute to the immune response of patients infected with SARS-CoV-2.
Posted: 22 January 2021 | Victoria Rees (Drug Target Review) | No comments yet
A new study has shown that previous coronavirus infection may contribute to the immune response of patients infected with SARS-CoV-2.
The results of a new study have suggested that the immune systems of people infected with COVID-19 may rely on antibodies created during infections from earlier coronaviruses to help fight the disease.
The study was conducted at Northern Arizona University and the Translational Genomics…
-
Business18 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business22 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Business14 hours agoDicker Data rides the AI trend to double digit growth
-
Business17 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy